🔗 Share this article Users Stopping Weight-Loss Jabs Regain Weight at a Quadrupled Rate Than Dieters Weight management often requires ongoing approaches. A recent study suggests that people who stop using blockbuster slimming jabs like Wegovy and Mounjaro tend to recover lost weight far faster than those who halt traditional lifestyle programs. Published data in a major medical journal shows that while overweight people often shed substantial amounts of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month upon discontinuation. "People using these drugs need to be informed of the potential of rapid rebound weight gain when the therapy concludes," cautioned researcher Dr. Susan Jebb. That rate of regain suggests a return to pre-treatment mass within about one and a half years. Weighing Therapies The research, which examined 37 of trials involving thousands of patients, contrasted the outcomes of these new drugs with older methods. Researchers emphasize that individuals who shed pounds through diet and exercise typically see a more gradual weight regain—around 0.1 kg a month—after stopping. Understanding the Quick Rebound Experts propose the mode of action of the jabs is key to understanding the amplified regain. The injections imitate a body's own chemical called GLP-1, which controls feelings of fullness. "Sustained high doses of GLP-1 levels several times higher than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist. "Stopping of this GLP-1 'fix' leads to hunger is unsuppressed, making excessive eating far more likely." An Ongoing Disease? Health authorities recommend the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications. Professionals say that, due to the significant potential of weight regain, the treatment is often life-long. This opinion is echoed by pharmaceutical companies, who note that the findings "underscore the chronic character of obesity," similar to managing conditions like hypertension. Patient Accounts Users who have stopped the jabs explain a powerful resurgence of appetite. "I experienced a switch that goes on and you're instantly ravenous," recalled one woman. This challenge is compounded if patients have not adopted permanent lifestyle or habit modifications during treatment. Widespread Adoption Survey data show that millions of adults in the UK have used these injections in the last 12 months, with desire being substantial. Use is greater among women compared to males. The 40s and 50s demographic shows the greatest usage rates. Many access the medications through private prescriptions rather than public health services. In conclusion, researchers emphasize that while these medications are potent agents for shedding pounds, they are not a standalone cure and long-term success hinges on integrated behavioural changes.
Weight management often requires ongoing approaches. A recent study suggests that people who stop using blockbuster slimming jabs like Wegovy and Mounjaro tend to recover lost weight far faster than those who halt traditional lifestyle programs. Published data in a major medical journal shows that while overweight people often shed substantial amounts of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month upon discontinuation. "People using these drugs need to be informed of the potential of rapid rebound weight gain when the therapy concludes," cautioned researcher Dr. Susan Jebb. That rate of regain suggests a return to pre-treatment mass within about one and a half years. Weighing Therapies The research, which examined 37 of trials involving thousands of patients, contrasted the outcomes of these new drugs with older methods. Researchers emphasize that individuals who shed pounds through diet and exercise typically see a more gradual weight regain—around 0.1 kg a month—after stopping. Understanding the Quick Rebound Experts propose the mode of action of the jabs is key to understanding the amplified regain. The injections imitate a body's own chemical called GLP-1, which controls feelings of fullness. "Sustained high doses of GLP-1 levels several times higher than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist. "Stopping of this GLP-1 'fix' leads to hunger is unsuppressed, making excessive eating far more likely." An Ongoing Disease? Health authorities recommend the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications. Professionals say that, due to the significant potential of weight regain, the treatment is often life-long. This opinion is echoed by pharmaceutical companies, who note that the findings "underscore the chronic character of obesity," similar to managing conditions like hypertension. Patient Accounts Users who have stopped the jabs explain a powerful resurgence of appetite. "I experienced a switch that goes on and you're instantly ravenous," recalled one woman. This challenge is compounded if patients have not adopted permanent lifestyle or habit modifications during treatment. Widespread Adoption Survey data show that millions of adults in the UK have used these injections in the last 12 months, with desire being substantial. Use is greater among women compared to males. The 40s and 50s demographic shows the greatest usage rates. Many access the medications through private prescriptions rather than public health services. In conclusion, researchers emphasize that while these medications are potent agents for shedding pounds, they are not a standalone cure and long-term success hinges on integrated behavioural changes.